Huina Wu1, Mingyuan Zou1, Xiaobo Fan1, Feiya Su1, Feng Xiao1, Meiling Zhou1, Yan Sun1, Fengfeng Zhao1, Guoqiu Wu2,3,4. 1. Medical School of Southeast University, Nanjing 210009, People's Republic of China. 2. Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, People's Republic of China. 3. Diagnostics Department, Medical School of Southeast University, Nanjing 210009, People's Republic of China. 4. Jiangsu Provincial Key Laboratory of Critical Care Medicine, Southeast University, Nanjing 210009, People's Republic of China.
Abstract
Influenza viruses and respiratory syncytial virus (RSV) have contributed to severe respiratory infections, causing huge economic and healthcare burdens. To achieve rapid and precise detection of influenza viruses and RSV, we proposed a catalytic hairpin assembly (CHA) combined with the lateral flow immunoassay (CHA-LFIA) detection method. The presence of the target RNA triggers the initiation of CHA circuits. H1/H2 complexes, the amplified signal products, which were labeled with digoxin and biotin, were detected with a highly sensitive lateral flow immunoassay system. The sensitivity of the CHA-LFIA system to influenza A and B viruses and RSV reached up to 1, 1, and 5 pM, respectively. In addition, this method exhibited excellent capability for differentiating between target RNA and base-mismatched RNA. The results demonstrated that an enzyme-free, rapid, highly sensitive, and specific method had been developed to detect influenza A and B viruses and RSV.
Influenza viruses and respiratory syncytial virus (RSV) have contributed to severe respiratory infections, causing huge economic and healthcare burdens. To achieve rapid and precise detection of influenza viruses and RSV, we proposed a catalytic hairpin assembly (CHA) combined with the lateral flow immunoassay (CHA-LFIA) detection method. The presence of the target RNA triggers the initiation of CHA circuits. H1/H2 complexes, the amplified signal products, which were labeled with digoxin and biotin, were detected with a highly sensitive lateral flow immunoassay system. The sensitivity of the CHA-LFIA system to influenza A and B viruses and RSV reached up to 1, 1, and 5 pM, respectively. In addition, this method exhibited excellent capability for differentiating between target RNA and base-mismatched RNA. The results demonstrated that an enzyme-free, rapid, highly sensitive, and specific method had been developed to detect influenza A and B viruses and RSV.
Influenza
viruses and respiratory syncytial virus (RSV) infections
are responsible for significant global morbidity, mortality, and healthcare
burden each year.[1−3] In particular, influenza viruses cause millions of
deaths worldwide each year, and RSV is responsible for 200,000 deaths
in a single year, posing a clinical and economic burden.[4−7] Moreover, the symptoms of influenza viruses and RSV infections are
cough, rhinorrhea, and fever, which are difficult to distinguish from
those of other respiratory virus infections.[8−10] Therefore,
a precise and rapid diagnostic method is of utmost importance. The
traditional viral culture is the gold standard for respiratory viral
infection diagnosis; however, it is time-consuming, with the viral
detection timeframe ranging from 2 to 14 days.[11−13] The transition
from a conventional viral culture to a reverse-transcription polymerase
chain reaction (RT-PCR) is a major leap. However, labor-intensive
procedures along with sophisticated equipment have greatly limited
its application in point-of-care analysis.[14−16] Therefore,
it is essential to develop a sensitive, specific, and convenient strategy
to detect influenza viruses and RSV.In recent years, nucleic
acid isothermal amplification techniques
have garnered extensive attention because of their simplicity, rapid
detection, and high sensitivity and specificity.[17] The isothermal nucleic amplification method can be performed
at specific temperatures in a constant-temperature water bath pot
to overcome the process of repeated heating and cooling.[18,19] Catalytic hairpin assembly (CHA) is an isothermal nucleic amplification
method that has promising applications. CHA, first proposed by Pierce
et al.,[20] is an enzyme-free isothermal
amplification that relies on a thermodynamically driven entropy gain
process to achieve exponential signal amplification.[21−25] Circuits in CHA provide rapid and efficient amplification with minimal
background and fast turnover rates.[26] Furthermore,
CHA can be adopted in various analytical formats, such as colorimetry,
surface plasmon resonance, electrochemistry, and Raman spectroscopy.[27−30] However, these strategies are complex, time-consuming, involve expensive
equipment, and rely on nanoparticles.In this study, a facile
and sensitive detection strategy for influenza
A virus (Flu A), influenza B virus (Flu B), and RSV was designed based
on a catalytic hairpin assembly and the lateral flow immunoassay (CHA–LFIA)
system. As shown in Scheme , the CHA–LFIA detection method consists of two parts:
(1) signal amplification by CHA and (2) fluorescence signal detection
by LFIA. The mixture of rationally designed probes Hairpin 1 (H1),
Hairpin 2 (H2), and target RNA was incubated in a constant-temperature
water bath pot for 15 min to produce large amounts of H1/H2 complexes.
The fluorescence signals were read between 10 and 30 min after the
addition of the CHA reaction solution. Moreover, the CHA–LFIA
detection system realizes quantitative detection. The fluorescence
and target RNA concentrations exhibited a good linear relationship
(R2 = 0.9915 for Flu A, R2 = 0.9830 for Flu B, and R2 = 0.9828 for RSV). In addition, this method exhibits excellent capability
for differentiating between the target RNA and base-mismatched RNA.
In brief, the CHA–LFIA system has the advantages of easy performance,
rapid detection, high accuracy, sensitivity, and specificity.
Scheme 1
Schematic of the CHA–LFIA System for Influenza Viruses and
RSV Detection. (A) Mechanism of the CHA Reaction. (B) Principle Applied
by the LFIA Strip to Detect H1/H2 Complexes Labeled with Digoxin and
Biotin.
Experimental
Section
Chemicals and Materials
The oligonucleotides
listed in Table S1 were synthesized and
purified by Sangon Biotech Co., Ltd. (Shanghai, China). Native-PAGE
gel and DNA loading buffer (6×) were purchased from Sangon Biotech
Co., Ltd. (Shanghai, China). Ultrapure water was obtained from a Millipore
water purification system.
Preparation of the CHA
Probes
Genome
sequences of influenza A and B viruses and RSV were obtained from
NCBI Gene Bank. Highly conserved regions of viruses were identified
by multiple sequence alignments, and hairpin probes were designed
based on genome conserved regions.Hairpin probes were designed
based on NUPACK,[31] and the ideal structures
of H1 and H2 were analyzed by mFold,[32] as
shown in Figure S1. H1 and H2 were diluted
in a 1× TNaK buffer (20 × 10–3 M Tris,
pH = 7.5; 140 × 10–3 M NaCl; 5 × 10–3 M KCl). For the pretreatment of hairpin probes, H1
and H2 were separately heated at 95 °C for 5 min and slowly cooled
down to room temperature.
Fluorescence Signal Monitoring
of the CHA
Reaction
The CHA reaction mixture containing H1 (300 nM),
H2 (300 nM), and target RNA (300 nM) to a total volume of 30 μL
was monitored using a CFX96 real-time system at intervals of 30 s.
H2 was labeled with a fluorescent reporter (FAM) and quencher dyes
(BHQ1) at opposite ends. As the CHA reaction progressed, a number
of H2 molecules opened and generated remarkable fluorescence signals.
For comparison, a mixture of H1 (300 nM), H2 (300 nM), and TNaK buffer
was measured without the addition of the target RNA.
Gel Electrophoresis Analysis
Native-PAGE
electrophoresis was performed to detect the CHA reaction. (Lane 1–7:
H1, H2, target RNA, H1 + H2, H1 + target RNA, H2 + target RNA, and
H1 + H2 + target RNA, respectively). The mixture was reacted at 37
°C in a water bath pot for 15 min. Thereafter, 15 μL of
the mixture was loaded onto a gel for electrophoresis analysis that
was performed at 120 V for 1 h in a 1× TAE buffer. The gels were
thereafter stained with 1% ethidium bromide for 10 min and imaged
under ultraviolet irradiation.
Optimization
of Assay Conditions
To improve the sensitivity of the detection
system, several parameters,
including the reaction temperature, ratio of H1 and H2, LFIA strip
detection time, and concentrations of H1 and H2, were systematically
optimized. The fluorescence signal (S) was defined by the fluorescence
value obtained by the mixture of H1, H2, and target RNA. In the absence
of the target RNA, the fluorescence signal produced by spontaneous
H1 and H2 binding served as the background signal (N). The signal-to-noise
ratio (S/N) was used as the evaluation criterion of condition optimization.
First, we optimized the reaction temperature of CHA. Briefly, H1,
H2, and target RNA were diluted in TNaK buffer, and the concentrations
of H1, H2, and target RNA were held at 300 nM. A reaction mixture
of H1, H2, and target RNA was incubated at varying temperatures (25,
30, 35, 40, 45, and 50 °C) in 300 μL. Second, the ratio
of H1 and H2 was optimized at the optimum temperature. H1 (100, 200,
300, and 400 nM) and H2 (100 nM) were mixed with the target RNA (100
nM), which were diluted in 300 μL of TNaK buffer for 15 min
incubation. Then, an experiment on the LFIA strip detection time was
performed. The mixture of H1, H2, and target RNA was incubated at
the optimum temperature, and 75 μL of the mixture was dropped
on the immunoassay strip. Thereafter, fluorescence signals were detected
every 5 min. During the optimal concentrations of H1 and H2, target
RNA was fixed at 1 nM. The concentrations of H1 were 2, 4, 40, and
200 nm, and the corresponding concentrations of H2 were 500 pm and
1, 10, and 50 nm based on the optimum ratio of H1 and H2 for Flu A.
Similarly, optimal concentrations of H1 and H2 for Flu B and RSV are
illustrated in Figure S2.
Sensitivity of CHA–LFIA
Under
optimized experimental conditions, H1 and H2 detected the target RNA
of varying concentrations in a virus preservation solution at 1 nM
and 800, 600, 500, 400, 200, 100, 50, 10, 5, 1, and 0 pM, similar
to the aforementioned procedure.
Specificity
of CHA–LFIA
To
evaluate the selectivity of the CHA–LFIA system, target RNA,
single-base-mismatched RNA (SM), and double-base-mismatched RNA (DM)
were detected using a procedure similar to that described previously.
Results and Discussion
Principle
of CHA–LFIA for Influenza
Viruses and RSV Detection
The principle of CHA–LFIA
is shown in Scheme . CHA is composed of three elements: target RNA and a pair of complementary
hairpin probes H1 and H2. H1 and H2 were labeled with biotin and digoxin
at the 5′ terminus, respectively, to facilitate follow-up immunoassay
strip testing. Without the target RNA, spontaneous hybridization between
H1 and H2 hardly occurs because the complementary domain is kinetically
blocked by hairpin stems.[33] However, when
the target RNA is present, the CHA reaction is triggered via a toehold-mediated
strand displacement reaction. In particular, the target RNA hybridizes
with the toehold of H1 and forms the H1/target RNA complex. Similarly,
the exposed H1 initiates assembly with H2 and forms the H1/H2 complex.
Gradually, the target RNA is displaced through strand displacement
and further participates in the cycle of hairpin opening and assembly.
Consequently, one copy of the target RNA can generate numerous H1/H2
complexes that produce significant signal amplification.Another
part of the CHA–LFIA system is the lateral flow immunoassay
strip. The construction of the test strip was based on our previous
study.[34] Briefly, the strip is composed
of a sample pad, conjugation pad, nitrocellulose membrane with a test
line (T), a control line (C), and an absorbent pad. The conjugation
pad was prepared with polyethylene (PE) nanoparticles labeled with
streptavidin (SA) and fluorophore Alexa Fluor 647. H1/H2 complexes
labeled with digoxin and biotin gradually flowed and were captured
by a prefixed digoxin antibody. Thereafter, PE nanoparticles labeled
with SA and fluorophore Alexa Fluor 647 were combined with the captured
H1/H2 complexes to form a sandwich hybridization complex. Finally,
fluorescence signals were detected using a fluorescence immunochromatographic
quantitative analyzer.
Feasibility of the CHA
Reaction
Real-time
fluorescence signals were monitored to validate the feasibility of
CHA. When the reaction solution contained the target RNA, it triggered
the recycling of the CHA reaction. H2 was labeled with FAM and BHQ1
at opposite ends. With the hairpin opening of H2, fluorescence signals
were detected by fluorescence resonance energy transfer. As the reaction
proceeded, the fluorescence signals rapidly increased. Owing to the
substrate concentration consumption, the reaction velocity became
slower and reached the platform period. Figure A–C shows the changes in fluorescence
signals as a function of the reaction time for Flu A (A), Flu B (B),
and RSV(C), respectively. In the presence of the target RNA, fluorescence
signals grew significantly. However, fluorescence signals barely changed
in the absence of the target RNA.
Figure 1
Feasibility of the CHA reaction. (A–C)
Real-time fluorescence
signals monitoring of the CHA reaction for Flu A (A), Flu (B), and
RSV (C). (D–F) Native polyacrylamide gel electrophoresis of
the CHA reaction for Flu A (D), Flu (E), and RSV (F). Lane 1: H1,
Lane 2: H2, Lane 3: target RNA, Lane 4: H1 + H2, Lane 5: H1 + target
RNA, Lane 6: H2 + target RNA, and Lane 7: H1 + H2 + target RNA.
Feasibility of the CHA reaction. (A–C)
Real-time fluorescence
signals monitoring of the CHA reaction for Flu A (A), Flu (B), and
RSV (C). (D–F) Native polyacrylamide gel electrophoresis of
the CHA reaction for Flu A (D), Flu (E), and RSV (F). Lane 1: H1,
Lane 2: H2, Lane 3: target RNA, Lane 4: H1 + H2, Lane 5: H1 + target
RNA, Lane 6: H2 + target RNA, and Lane 7: H1 + H2 + target RNA.Native polyacrylamide gel electrophoresis was also
performed to
reveal the feasibility of CHA via electrophoretic bands. As shown
in Figure D–F,
Lanes 1 (H1), 2 (H2), and 3 (target RNA) exhibited a clear electrophoresis
band. When the target RNA was absent (Lane 4), most H1 and H2 could
coexist. Research showed that there was approximately 3.5% of H1 and
H2 spontaneously hybridized without an initiator.[20] When samples contained H1 and H2 and target RNA, an obvious
band (Lane 7) appeared representing the product H1/H2 complexes.
Optimization of Assay Conditions
As shown
in Figure A–C,
20 cycles reached the platform period, which was approximately
15 min. Thus, 15 min is sufficient for the CHA reaction. Optimization
of assay conditions for Flu A is shown in Figure . The fluorescence signal values are shown
in Figure A at varying
temperatures. The signal-to-noise ratio (S/N) of fluorescence (Figure D) showed that the
optimum temperature was 35 °C; Figure E shows that the optimal ratio of H1/H2 was
4:1 considering the S/N and cost. With the increasing concentration
of H1 and H2, both the fluorescence and background signals increased
(Figure C). When the
concentration of H2 was 1 nM, S/N reached a maximum (Figure F). The optimized conditions
for flu B and RSV are shown in Figures S2 and S3. Optimum temperatures were 25 and 30 °C for Flu B and
RSV, respectively; the optimal ratios of H1/H2 were 1:1 and 1:3 for
Flu B and RSV, respectively; the optimum concentration of H2 was 1
and 3 nM for Flu B and RSV, respectively. The fluorescence value fluctuated
substantially during the first 10 min, and there was nearly no clear
change from 10 to 30 min (Figure S4). Thus,
an immunoassay strip was detected between 10 and 30 min after dropping
the CHA reaction solution.
Figure 2
Optimization of assay conditions for Flu A.
(A, D) Reaction temperature
and S/N of CHA; (B, E) optimization of the ratio of H1/H2 and S/N;
(C, F) concentration and S/N of H1 and H2. Data are represented as
the means ± standard deviation (SD) (n = 3).
Optimization of assay conditions for Flu A.
(A, D) Reaction temperature
and S/N of CHA; (B, E) optimization of the ratio of H1/H2 and S/N;
(C, F) concentration and S/N of H1 and H2. Data are represented as
the means ± standard deviation (SD) (n = 3).
Sensitivity of the CHA–LFIA
Owing to the complex biological environment of oropharyngeal buffer,
there are numerous factors that may influence the outcome of the investigation.
To make the detection environment closer to clinical detection, H1,
H2, and target RNA of subsequent experiments were studied in an oropharyngeal
virus preservation solution.As shown in Figure A–C, the fluorescence value decreased
gradually as the concentration of target RNA decreased. Figure D–F shows an excellent
linear relationship between the fluorescence value (Y) and target RNA concentration (X), and the linear
equations were expressed as follows: Y = 6.696*X + 1606 (R2 = 0.9915), Y = 11.93*X + 1138 (R2 = 0.9830), and Y = 12.06*X + 1339 (R2 = 0.9828) for Flu A, Flu
B, and RSV, respectively. The cutoff values (the mean value plus 3
× the standard deviation for negative samples)[35] were 1613, 352, and 885 for Flu A, Flu B, and RSV, respectively.
The CHA–LFIA system exhibited a wide linear range with limits
of detection of 1, 1, and 5 pM, respectively.
Figure 3
Sensitivity of the CHA–LFIA.
(A–C) Fluorescence value
for varying concentrations of target RNA in the virus preservation
solution at 1 nM and 800, 600, 500, 400, 200, 100, 50, 10, 5, 1, and
0 pM for Flu A (A), Flu B (B), and RSV (C). (D–F) Calibration
curve of the fluorescence value against varying concentrations of
the target RNA for Flu A (D), Flu B (E), and RSV (F). Data are represented
as the means ± SD (n = 3).
Sensitivity of the CHA–LFIA.
(A–C) Fluorescence value
for varying concentrations of target RNA in the virus preservation
solution at 1 nM and 800, 600, 500, 400, 200, 100, 50, 10, 5, 1, and
0 pM for Flu A (A), Flu B (B), and RSV (C). (D–F) Calibration
curve of the fluorescence value against varying concentrations of
the target RNA for Flu A (D), Flu B (E), and RSV (F). Data are represented
as the means ± SD (n = 3).
Specificity of the CHA–LFIA
To evaluate
the selectivity of the CHA–LFIA system, target
RNA, SM, and DM were detected under similar conditions. As shown in Figure , in comparison with
the target RNA, the fluorescence value of mismatched RNA was significantly
lower, demonstrating that this CHA–LFIA detection method had
excellent selectivity and high discrimination capability.
Figure 4
Selective investigation
of the target RNA, SM, and DM with a concentration
of 1 nM for Flu A (A), Flu B (B), and RSV (C). Data are represented
as the means ± SD (n = 3).
Selective investigation
of the target RNA, SM, and DM with a concentration
of 1 nM for Flu A (A), Flu B (B), and RSV (C). Data are represented
as the means ± SD (n = 3).
Conclusions
The CHA–LFIA detection
system required only 30 min to obtain
results and had excellent detection performance, high sensitivity
to detect targets as low as 1 pM, and excellent specificity to identify
the target. In addition, this system did not require complicated and
expensive detection equipment, only a water bath pot and a portable
immunofluorescence detection analyzer that facilitated point-of-care
diagnostic testing. The CHA–LFIA detection system has an exponential
signal amplification capability. In comparison with the CHA with fluorescence,
as shown in Figure S4, the minimum detection
was 1 nM for influenza A virus. Fluorescence signals were further
amplified by approximately 3 orders of magnitude via a lateral flow
immunoassay strip that is an innovation from the traditional fluorescence
signal detection of CHA.In conclusion, we developed a facile,
rapid, sensitive, and convenient
strategy for detecting influenza A virus, influenza B virus, and RSV
by coupling the CHA and lateral flow immunoassay strip. By designing
the probe precisely and optimizing experimental conditions, the proposed
CHA–LFIA system exhibited promising performance in detecting
influenza A virus, influenza B virus, and RSV with a minimum detection
limit of 1, 1, and 5 pM, respectively. Owing to its high sensitivity,
low cost, and rapid detection, the proposed CHA–LFIA system
provides a new avenue for influenza viruses and RSV detection in clinical
fields.
Authors: Daniel Stadlbauer; Leon de Waal; Edith Beaulieu; Shirin Strohmeier; Edwin J B Veldhuis Kroeze; Philippe Boutet; Albert D M E Osterhaus; Florian Krammer; Bruce L Innis; Raffael Nachbagauer; Koert J Stittelaar; Corey P Mallett Journal: NPJ Vaccines Date: 2021-03-19 Impact factor: 7.344